[1]
Moon, H.W.; Han, H.G.; Jeon, Y.J. Protein quality control in the endoplasmic reticulum and cancer. Int. J. Mol. Sci., 2018, 19(10), E3020.
[2]
Oakes, S.A.; Papa, F.R. The role of endoplasmic reticulum stress in human pathology. Annu. Rev. Pathol., 2015, 10, 173-194.
[3]
Afroze, D.; Kumar, A. ER stress in skeletal muscle remodeling and myopathies. FEBS J., 2019, 286(2), 379-398.
[4]
Hetz, C.; Chevet, E.; Oakes, S.A. Proteostasis control by the unfolded protein response. Nat. Cell Biol., 2015, 17(7), 829-838.
[5]
Wang, M.; Kaufman, R.J. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat. Rev. Cancer, 2014, 14(9), 581-597.
[6]
Rozpedek, W.; Markiewicz, L.; Diehl, J.A.; Pytel, D.; Majsterek, I. Unfolded protein response and PERK kinase as a new therapeutic target in the pathogenesis of alzheimer’s disease. Curr. Med. Chem., 2015, 22(27), 3169-3184.
[7]
So, J.S. Roles of endoplasmic reticulum stress in immune responses. Mol. Cells, 2018, 41(8), 705-716.
[8]
Chaudhari, N.; Talwar, P.; Parimisetty, A.; Lefebvre d’Hellencourt, C.; Ravanan, P. A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front. Cell. Neurosci., 2014, 8, 213.
[9]
Grootjans, J.; Kaser, A.; Kaufman, R.J.; Blumberg, R.S. The unfolded protein response in immunity and inflammation. Nat. Rev. Immunol., 2016, 16(8), 469-484.
[10]
Han, J.; Song, B.; Kim, J.; Kodali, V.K.; Pottekat, A.; Wang, M.; Hassler, J.; Wang, S.; Pennathur, S.; Back, S.H.; Katze, M.G.; Kaufman, R.J. Antioxidants complement the requirement for protein chaperone function to maintain beta-cell function and glucose homeostasis. Diabetes, 2015, 64(8), 2892-2904.
[11]
Kang, K.A.; Kim, J.K.; Jeong, Y.J.; Na, S.Y.; Hyun, J.W. Dictyopteris undulata extract induces apoptosis via induction of endoplasmic reticulum stress in human colon cancer cells. J. Cancer Prev., 2014, 19(2), 118-124.
[12]
Yadav, R.K.; Chae, S.W.; Kim, H.R.; Chae, H.J. Endoplasmic reticulum stress and cancer. J. Cancer Prev., 2014, 19(2), 75-88.
[13]
Ron, D.; Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol., 2007, 8(7), 519-529.
[14]
Walter, P.; Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science, 2011, 334(6059), 1081-1086.
[15]
Shore, G.C.; Papa, F.R.; Oakes, S.A. Signaling cell death from the endoplasmic reticulum stress response. Curr. Opin. Cell Biol., 2011, 23(2), 143-149.
[16]
Song, J.; Kim, B.C.; Nguyen, D.T.; Samidurai, M.; Choi, S.M. Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity. Neuroscience, 2017, 358, 336-348.
[17]
Ghosh, R.; Wang, L.; Wang, E.S.; Perera, B.G.; Igbaria, A.; Morita, S.; Prado, K.; Thamsen, M.; Caswell, D.; Macias, H.; Weiberth, K.F.; Gliedt, M.J.; Alavi, M.V.; Hari, S.B.; Mitra, A.K.; Bhhatarai, B.; Schürer, S.C.; Snapp, E.L.; Gould, D.B.; German, M.S.; Backes, B.J.; Maly, D.J.; Oakes, S.A.; Papa, F.R. Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress. Cell, 2014, 158(3), 534-548.
[18]
Han, D.; Lerner, A.G.; Vande Walle, L.; Upton, J.P.; Xu, W.; Hagen, A.; Backes, B.J.; Oakes, S.A.; Papa, F.R. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell, 2009, 138(3), 562-575.
[19]
Mori, K. Signalling pathways in the unfolded protein response: development from yeast to mammals. J. Biochem., 2009, 146(6), 743-750.
[20]
Calfon, M.; Zeng, H.; Urano, F.; Till, J.H.; Hubbard, S.R.; Harding, H.P.; Clark, S.G.; Ron, D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature, 2002, 415(6867), 92-96.
[21]
Yoshida, H.; Matsui, T.; Yamamoto, A.; Okada, T.; Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell, 2001, 107(7), 881-891.
[22]
Majumder, M.; Huang, C.; Snider, M.D.; Komar, A.A.; Tanaka, J.; Kaufman, R.J.; Krokowski, D.; Hatzoglou, M. A novel feedback loop regulates the response to endoplasmic reticulum stress via the cooperation of cytoplasmic splicing and mRNA translation. Mol. Cell. Biol., 2012, 32(5), 992-1003.
[23]
Shen, X.; Ellis, R.E.; Lee, K.; Liu, C.Y.; Yang, K.; Solomon, A.; Yoshida, H.; Morimoto, R.; Kurnit, D.M.; Mori, K.; Kaufman, R.J. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell, 2001, 107(7), 893-903.
[24]
Hollien, J.; Lin, J.H.; Li, H.; Stevens, N.; Walter, P.; Weissman, J.S. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J. Cell Biol., 2009, 186(3), 323-331.
[25]
Maurel, M.; Chevet, E.; Tavernier, J.; Gerlo, S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci., 2014, 39(5), 245-254.
[26]
Lerner, A.G.; Upton, J.P.; Praveen, P.V.; Ghosh, R.; Nakagawa, Y.; Igbaria, A.; Shen, S.; Nguyen, V.; Backes, B.J.; Heiman, M.; Heintz, N.; Greengard, P.; Hui, S.; Tang, Q.; Trusina, A.; Oakes, S.A.; Papa, F.R. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab., 2012, 16(2), 250-264.
[27]
Upton, J.P.; Wang, L.; Han, D.; Wang, E.S.; Huskey, N.E.; Lim, L.; Truitt, M.; McManus, M.T.; Ruggero, D.; Goga, A.; Papa, F.R.; Oakes, S.A. IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2. Science, 2012, 338(6108), 818-822.
[28]
Zhou, R.; Tardivel, A.; Thorens, B.; Choi, I.; Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol., 2010, 11(2), 136-140. [http://dx.doi.org/10.1038/ni.1831]. [PMID: 20023662].
[29]
Galindo-Hernandez, O.; Cordova-Guerrero, I.; Diaz-Rubio, L.J.; Pulido-Capiz, A.; Diaz-Villanueva, J.F.; Castaneda-Sanchez, C.Y.; Serafin-Higuera, N.; Garcia-Gonzalez, V. Protein translation associated to PERK arm is a new target for regulation of metainflammation: A connection with hepatocyte cholesterol. J. Cell. Biochem., 2018.
[30]
Axten, J.M. Protein kinase R(PKR)-like endoplasmic reticulum kinase (PERK) inhibitors: a patent review (2010-2015). Expert Opin. Ther. Pat., 2017, 27(1), 37-48.
[31]
Jennings, M.D.; Pavitt, G.D. eIF5 has GDI activity necessary for translational control by eIF2 phosphorylation. Nature, 2010, 465(7296), 378-381.
[32]
Kim, E.; Kim, J.H.; Seo, K.; Hong, K.Y.; An, S.W.A.; Kwon, J.; Lee, S.V.; Jang, S.K. eIF2A, an initiator tRNA carrier refractory to eIF2α kinases, functions synergistically with eIF5B. Cell. Mol. Life Sci., 2018, 75(23), 4287-4300.
[33]
Jackson, R.J.; Hellen, C.U.; Pestova, T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol., 2010, 11(2), 113-127.
[34]
Malhotra, J.D.; Kaufman, R.J. ER stress and its functional link to mitochondria: role in cell survival and death. Cold Spring Harb. Perspect. Biol., 2011, 3(9), a004424.
[35]
Sidrauski, C.; Acosta-Alvear, D.; Khoutorsky, A.; Vedantham, P.; Hearn, B.R.; Li, H.; Gamache, K.; Gallagher, C.M.; Ang, K.K.; Wilson, C.; Okreglak, V.; Ashkenazi, A.; Hann, B.; Nader, K.; Arkin, M.R.; Renslo, A.R.; Sonenberg, N.; Walter, P. Pharmacological brake-release of mRNA translation enhances cognitive memory. eLife, 2013, 2, e00498.
[36]
Harding, H.P.; Novoa, I.; Zhang, Y.; Zeng, H.; Wek, R.; Schapira, M.; Ron, D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell, 2000, 6(5), 1099-1108.
[37]
Rozpedek, W.; Pytel, D.; Mucha, B.; Leszczynska, H.; Diehl, J.A.; Majsterek, I. The Role of the PERK/eIF2alpha/ATF4/CHOP Signaling pathway in tumor progression during endoplasmic reticulum stress. Curr. Mol. Med., 2016, 16(6), 533-544.
[38]
Li, Y.; Guo, Y.; Tang, J.; Jiang, J.; Chen, Z. New insights into the roles of CHOP-induced apoptosis in ER stress. Acta Biochim. Biophys. Sin. (Shanghai), 2014, 46(8), 629-640.
[39]
Zhang, P.; Sun, Q.; Zhao, C.; Ling, S.; Li, Q.; Chang, Y.Z.; Li, Y. HDAC4 protects cells from ER stress induced apoptosis through interaction with ATF4. Cell. Signal., 2014, 26(3), 556-563.
[40]
Li, Y.; Guo, Y.; Tang, J.; Jiang, J.; Chen, Z. New insights into the roles of CHOP-induced apoptosis in ER stress. Acta Biochim. Biophys. Sin. (Shanghai), 2015, 47(2), 146-147.
[41]
Cildir, G.; Low, K.C.; Tergaonkar, V. Noncanonical NF-kappaB signaling in health and disease. Trends Mol. Med., 2016, 22(5), 414-429.
[42]
Deng, J.; Lu, P.D.; Zhang, Y.; Scheuner, D.; Kaufman, R.J.; Sonenberg, N.; Harding, H.P.; Ron, D. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol. Cell. Biol., 2004, 24(23), 10161-10168.
[43]
Gardner, B.M.; Pincus, D.; Gotthardt, K.; Gallagher, C.M.; Walter, P. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb. Perspect. Biol., 2013, 5(3), a013169.
[44]
Haze, K.; Yoshida, H.; Yanagi, H.; Yura, T.; Mori, K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell, 1999, 10(11), 3787-3799.
[45]
Cao, S.S.; Kaufman, R.J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal., 2014, 21(3), 396-413.
[46]
Garcia-Carbonero, N.; Li, W.; Cabeza-Morales, M.; Martinez-Useros, J.; Garcia-Foncillas, J. New hope for pancreatic ductal adenocarcinoma treatment targeting endoplasmic reticulum stress Response: A Systematic Review. Int. J. Mol. Sci., 2018, 19(9), E2468.
[47]
Masciarelli, S.; Capuano, E.; Ottone, T.; Divona, M.; De Panfilis, S.; Banella, C.; Noguera, N.I.; Picardi, A.; Fontemaggi, G.; Blandino, G.; Lo-Coco, F.; Fazi, F. Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress. Leukemia, 2018, 32(2), 285-294.
[48]
Nadanaka, S.; Okada, T.; Yoshida, H.; Mori, K. Role of disulfide bridges formed in the luminal domain of ATF6 in sensing endoplasmic reticulum stress. Mol. Cell. Biol., 2007, 27(3), 1027-1043.
[49]
Hagerling, C.; Casbon, A.J.; Werb, Z. Balancing the innate immune system in tumor development. Trends Cell Biol., 2015, 25(4), 214-220.
[50]
Nagelkerke, A.; Bussink, J.; Sweep, F.C.; Span, P.N. The unfolded protein response as a target for cancer therapy. Biochim. Biophys. Acta, 2014, 1846(2), 277-284.
[51]
Cao, S.S.; Kaufman, R.J. Unfolded protein response. Curr. Biol., 2012, 22(16), R622-R626.
[52]
Tay, K.H.; Luan, Q.; Croft, A.; Jiang, C.C.; Jin, L.; Zhang, X.D.; Tseng, H.Y. Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress. Cell. Signal., 2014, 26(2), 287-294.
[53]
Darling, N.J.; Cook, S.J. The role of MAPK signalling pathways in the response to endoplasmic reticulum stress. Biochim. Biophys. Acta, 2014, 1843(10), 2150-2163.
[54]
Wang, P.; Li, J.; Tao, J.; Sha, B. The luminal domain of the ER stress sensor protein PERK binds misfolded proteins and thereby triggers PERK oligomerization. J. Biol. Chem., 2018, 293(11), 4110-4121.
[55]
Cui, W.; Li, J.; Ron, D.; Sha, B. The structure of the PERK kinase domain suggests the mechanism for its activation. Acta Crystallogr. D Biol. Crystallogr., 2011, 67(Pt 5), 423-428.
[56]
Wang, P.; Li, J.; Sha, B. The ER stress sensor PERK luminal domain functions as a molecular chaperone to interact with misfolded proteins. Acta Crystallogr. D Struct. Biol., 2016, 72(Pt 12), 1290-1297.
[57]
Amin-Wetzel, N.; Saunders, R.A.; Kamphuis, M.J.; Rato, C.; Preissler, S.; Harding, H.P.; Ron, D. A J-Protein co-chaperone recruits BiP to monomerize ire1 and repress the unfolded protein response. Cell, 2017, 171(7), 1625-1637.
[58]
Karagöz, G.E.; Acosta-Alvear, D.; Nguyen, H.T.; Lee, C.P.; Chu, F.; Walter, P. An unfolded protein-induced conformational switch activates mammalian IRE1. eLife, 2017, 6, 6.
[59]
Gardner, B.M.; Walter, P. Unfolded proteins are Ire1-activating ligands that directly induce the unfolded protein response. Science, 2011, 333(6051), 1891-1894.
[60]
Wang, J.; Lee, J.; Liem, D.; Ping, P. HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum. Gene, 2017, 618, 14-23.
[61]
Wang, M.; Kaufman, R.J. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature, 2016, 529(7586), 326-335.
[62]
Moenner, M.; Pluquet, O.; Bouchecareilh, M.; Chevet, E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res., 2007, 67(22), 10631-10634.
[63]
Koumenis, C. ER stress, hypoxia tolerance and tumor progression. Curr. Mol. Med., 2006, 6(1), 55-69.
[64]
Lee, A.S.; Hendershot, L.M. ER stress and cancer. Cancer Biol. Ther., 2006, 5(7), 721-722.
[65]
Cubillos-Ruiz, J.R.; Bettigole, S.E.; Glimcher, L.H. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell, 2017, 168(4), 692-706.
[66]
Chen, X.; Iliopoulos, D.; Zhang, Q.; Tang, Q.; Greenblatt, M.B.; Hatziapostolou, M.; Lim, E.; Tam, W.L.; Ni, M.; Chen, Y.; Mai, J.; Shen, H.; Hu, D.Z.; Adoro, S.; Hu, B.; Song, M.; Tan, C.; Landis, M.D.; Ferrari, M.; Shin, S.J.; Brown, M.; Chang, J.C.; Liu, X.S.; Glimcher, L.H. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature, 2014, 508(7494), 103-107.
[67]
Bobrovnikova-Marjon, E.; Grigoriadou, C.; Pytel, D.; Zhang, F.; Ye, J.; Koumenis, C.; Cavener, D.; Diehl, J.A. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene, 2010, 29(27), 3881-3895.
[68]
Hong, S.Y.; Hagen, T. Multiple myeloma Leu167Ile (c.499C>A) mutation prevents XBP1 mRNA splicing. Br. J. Haematol., 2013, 161(6), 898-901.
[69]
Hazari, Y.M.; Bashir, A.; Haq, E.U.; Fazili, K.M. Emerging tale of UPR and cancer: an essentiality for malignancy. Tumour Biol., 2016, 37(11), 14381-14390.
[70]
Shapiro, D.J.; Livezey, M.; Yu, L.; Zheng, X.; Andruska, N.; Anticipatory, U.P.R. Activation: A protective pathway and target in cancer. Trends Endocrinol. Metab., 2016, 27(10), 731-741.
[71]
Li, X.X.; Zhang, H.S.; Xu, Y.M.; Zhang, R.J.; Chen, Y.; Fan, L.; Qin, Y.Q.; Liu, Y.; Li, M.; Fang, J. Knockdown of IRE1α inhibits colonic tumorigenesis through decreasing β-catenin and IRE1α targeting suppresses colon cancer cells. Oncogene, 2017, 36(48), 6738-6746.
[72]
Cubillos-Ruiz, J.R.; Bettigole, S.E.; Glimcher, L.H. Molecular Pathways: Immunosuppressive roles of IRE1alpha-XBP1 signaling in dendritic cells of the tumor microenvironment. Clin. Cancer Res., 2016, 22(9), 2121-2126.
[73]
Inguscio, V.; Panzarini, E.; Dini, L. Autophagy contributes to the death/survival balance in cancer photodynamic therapy. Cells, 2012, 1(3), 464-491.
[74]
Karali, E.; Bellou, S.; Stellas, D.; Klinakis, A.; Murphy, C.; Fotsis, T. VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress. Mol. Cell, 2014, 54(4), 559-572.
[75]
Schewe, D.M.; Aguirre-Ghiso, J.A. ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc. Natl. Acad. Sci. USA, 2008, 105(30), 10519-10524.
[76]
Chen, X.L.; Fu, J.P.; Shi, J.; Wan, P.; Cao, H.; Tang, Z.M. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway. Mol. Med. Rep., 2015, 12(6), 8229-8236.
[77]
Wilhelm, T.; Bick, F.; Peters, K.; Mohta, V.; Tirosh, B.; Patterson, J.B.; Kharabi-Masouleh, B.; Huber, M. Infliction of proteotoxic stresses by impairment of the unfolded protein response or proteasomal inhibition as a therapeutic strategy for mast cell leukemia. Oncotarget, 2017, 9(3), 2984-3000.
[78]
Rojas-Rivera, D.; Delvaeye, T.; Roelandt, R.; Nerinckx, W.; Augustyns, K.; Vandenabeele, P.; Bertrand, M.J.M. When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157. Cell Death Differ., 2017, 24(6), 1100-1110.
[79]
Axten, J.M.; Romeril, S.P.; Shu, A.; Ralph, J.; Medina, J.R.; Feng, Y.; Li, W.H.; Grant, S.W.; Heerding, D.A.; Minthorn, E.; Mencken, T.; Gaul, N.; Goetz, A.; Stanley, T.; Hassell, A.M.; Gampe, R.T.; Atkins, C.; Kumar, R. Discovery of GSK2656157: An optimized PERK inhibitor selected for preclinical development. ACS Med. Chem. Lett., 2013, 4(10), 964-968.
[80]
Krishnamoorthy, J.; Rajesh, K.; Mirzajani, F.; Kesoglidou, P.; Papadakis, A.I.; Koromilas, A.E. Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications. Cell Cycle, 2014, 13(5), 801-806.
[81]
Jiang, X.; Wei, Y.; Zhang, T.; Zhang, Z.; Qiu, S.; Zhou, X.; Zhang, S. Effects of GSK2606414 on cell proliferation and endoplasmic reticulum stressassociated gene expression in retinal pigment epithelial cells. Mol. Med. Rep., 2017, 15(5), 3105-3110.
[82]
García-González, P.; Cabral-Miranda, F.; Hetz, C.; Osorio, F. Interplay between the unfolded protein response and immune function in the development of neurodegenerative diseases. Front. Immunol., 2018, 9, 2541.
[83]
Smith, H.L.; Mallucci, G.R. The unfolded protein response: mechanisms and therapy of neurodegeneration. Brain, 2016, 139(Pt 8), 2113-2121.
[84]
Rahman, S.; Jan, A.T.; Ayyagari, A.; Kim, J.; Kim, J.; Minakshi, R. Entanglement of UPRER in Aging driven neurodegenerative diseases. Front. Aging Neurosci., 2017, 9, 341.
[85]
Roussel, B.D.; Kruppa, A.J.; Miranda, E.; Crowther, D.C.; Lomas, D.A.; Marciniak, S.J. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol., 2013, 12(1), 105-118.
[86]
Remondelli, P.; Renna, M. The endoplasmic reticulum unfolded protein response in neurodegenerative disorders and its potential therapeutic significance. Front. Mol. Neurosci., 2017, 10, 187.
[87]
Nisbet, R.M.; Polanco, J.C.; Ittner, L.M.; Götz, J. Tau aggregation and its interplay with amyloid-β. Acta Neuropathol., 2015, 129(2), 207-220.
[88]
Rajmohan, R.; Reddy, P.H. Amyloid-Beta and phosphorylated tau accumulations cause abnormalities at synapses of alzheimer’s disease neurons. J. Alzheimers Dis., 2017, 57(4), 975-999.
[89]
Fan, B.; Sun, Y.J.; Liu, S.Y.; Che, L.; Li, G.Y. Neuroprotective Strategy in retinal degeneration: suppressing ER stress-induced cell death via inhibition of the mTOR Signal. Int. J. Mol. Sci., 2017, 18(1), E201.
[90]
Devi, L.; Ohno, M. PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer’s disease. Neurobiol. Aging, 2014, 35(10), 2272-2281.
[91]
Hashimoto, S.; Ishii, A.; Kamano, N.; Watamura, N.; Saito, T.; Ohshima, T.; Yokosuka, M.; Saido, T.C. Endoplasmic reticulum stress responses in mouse models of Alzheimer’s disease: Overexpression paradigm versus knockin paradigm. J. Biol. Chem., 2018, 293(9), 3118-3125.
[92]
Gitler, A.D.; Dhillon, P.; Shorter, J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis. Model. Mech., 2017, 10(5), 499-502.
[93]
Cornejo, V.H.; Hetz, C. The unfolded protein response in Alzheimer’s disease. Semin. Immunopathol., 2013, 35(3), 277-292.
[94]
Ma, T.; Trinh, M.A.; Wexler, A.J.; Bourbon, C.; Gatti, E.; Pierre, P.; Cavener, D.R.; Klann, E. Suppression of eIF2α kinases alleviates Alzheimer’s disease-related plasticity and memory deficits. Nat. Neurosci., 2013, 16(9), 1299-1305.
[95]
Ohno, M. Roles of eIF2α kinases in the pathogenesis of Alzheimer’s disease. Front. Mol. Neurosci., 2014, 7, 22.
[96]
Halliday, M.; Radford, H.; Zents, K.A.M.; Molloy, C.; Moreno, J.A.; Verity, N.C.; Smith, E.; Ortori, C.A.; Barrett, D.A.; Bushell, M.; Mallucci, G.R. Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice. Brain, 2017, 140(6), 1768-1783.
[97]
Halliday, M.; Mallucci, G.R. Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memory. Neuropathol. Appl. Neurobiol., 2015, 41(4), 414-427.
[98]
Scheper, W.; Hoozemans, J.J. The unfolded protein response in neurodegenerative diseases: a neuropathological perspective. Acta Neuropathol., 2015, 130(3), 315-331.
[99]
Radford, H.; Moreno, J.A.; Verity, N.; Halliday, M.; Mallucci, G.R. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathol., 2015, 130(5), 633-642.
[100]
Marré, M.L.; Profozich, J.L.; Coneybeer, J.T.; Geng, X.; Bertera, S.; Ford, M.J.; Trucco, M.; Piganelli, J.D. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes. J. Autoimmun., 2016, 72, 33-46.
[101]
Arunagiri, A.; Haataja, L.; Cunningham, C.N.; Shrestha, N.; Tsai, B.; Qi, L.; Liu, M.; Arvan, P. Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes. Ann. N. Y. Acad. Sci., 2018, 1418(1), 5-19.
[102]
Wang, R.; Munoz, E.E.; Zhu, S.; McGrath, B.C.; Cavener, D.R. Perk gene dosage regulates glucose homeostasis by modulating pancreatic β-cell functions. PLoS One, 2014, 9(6), e99684.
[103]
Ariyasu, D.; Yoshida, H.; Hasegawa, Y. Endoplasmic reticulum (ER) stress and endocrine disorders. Int. J. Mol. Sci., 2017, 18(2), E382.
[104]
Sowers, C.R.; Wang, R.; Bourne, R.A.; McGrath, B.C.; Hu, J.; Bevilacqua, S.C.; Paton, J.C.; Paton, A.W.; Collardeau-Frachon, S.; Nicolino, M.; Cavener, D.R. The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones. J. Biol. Chem., 2018, 293(14), 5134-5149. [http://dx.doi.org/10.1074/jbc.M117.813790]. [PMID: 29444822].
[105]
Wang, R.; McGrath, B.C.; Kopp, R.F.; Roe, M.W.; Tang, X.; Chen, G.; Cavener, D.R. Insulin secretion and Ca2+ dynamics in β-cells are regulated by PERK (EIF2AK3) in concert with calcineurin. J. Biol. Chem., 2013, 288(47), 33824-33836.
[106]
Gupta, S.; McGrath, B.; Cavener, D.R. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes, 2010, 59(8), 1937-1947.
[107]
Kefalas, G.; Larose, L. PERK leads a hub dictating pancreatic β cell homoeostasis. Biol. Cell, 2018, 110(2), 27-32.
[108]
Al-Sinani, S.; Al-Yaarubi, S.; Sharef, S.W.; Al-Murshedi, F.; Al-Maamari, W. Novel mutation in wolcott-rallison syndrome with variable expression in two omani siblings. Oman Med. J., 2015, 30(2), 138-141.
[109]
Szabat, M.; Page, M.M.; Panzhinskiy, E.; Skovsø, S.; Mojibian, M.; Fernandez-Tajes, J.; Bruin, J.E.; Bround, M.J.; Lee, J.T.; Xu, E.E.; Taghizadeh, F.; O’Dwyer, S.; van de Bunt, M.; Moon, K.M.; Sinha, S.; Han, J.; Fan, Y.; Lynn, F.C.; Trucco, M.; Borchers, C.H.; Foster, L.J.; Nislow, C.; Kieffer, T.J.; Johnson, J.D. Reduced Insulin production relieves endoplasmic reticulum stress and induces beta cell proliferation. Cell Metab., 2016, 23(1), 179-193.
[110]
Hiraoka, H.; Nakahara, K.; Kaneko, Y.; Akiyama, S.; Okuda, K.; Iwawaki, T.; Fujimura, M.; Kumagai, Y.; Takasugi, N.; Uehara, T. Modulation of unfolded protein response by methylmercury. Biol. Pharm. Bull., 2017, 40(9), 1595-1598.
[111]
Usui, M.; Yamaguchi, S.; Tanji, Y.; Tominaga, R.; Ishigaki, Y.; Fukumoto, M.; Katagiri, H.; Mori, K.; Oka, Y.; Ishihara, H. Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance. Metabolism, 2012, 61(8), 1118-1128.
[112]
Nozaki, Ji.; Kubota, H.; Yoshida, H.; Naitoh, M.; Goji, J.; Yoshinaga, T.; Mori, K.; Koizumi, A.; Nagata, K. The endoplasmic reticulum stress response is stimulated through the continuous activation of transcription factors ATF6 and XBP1 in Ins2+/Akita pancreatic beta cells. Genes Cells, 2004, 9(3), 261-270.